The aim was to determine whether reperfusion with either neutrophil free reperfusate or perfusate containing only pyruvate as the metabolic substrate would alter the protection against infarction afforded by preconditioning. Methods: Rabbit hearts (n=4-14 per group) underwent 30 minutes of regional ischaemia followed by 120 minutes of reperfusion. Blood reperfused groups experienced both ischaemia and reperfusion in situ while Krebs reperfused groups experienced regional ischaemia in situ but were reperfused with Krebs buffer in vitro. In another group, glucose in Krebs buffer was replaced by pyruvate. Results: Preconditioning with 5 minutes regional ischaemia caused smaller infarct size in the blood reperfused hearts: 43.O(SEM 5.4)% v 8.8(4.2)%. In Krebs reperfused hearts, preconditioning caused a similar reduction of infarct size [49.9(2.5)% v 22.9(4.3)%] which was not different from that seen in the blood reperfused hearts. Replacing the glucose in the Krebs buffer by pyruvate also had no effect on infarct size in either the control or the preconditioned hearts [40.9(6.1)% v 11.8(5.2)%]. Histology of the ischaemic zones revealed 59.6(15.0) neutrophils per 10 high power fields in hearts reperfused in situ but only 2.6(0.6) in Krebs reperfused hearts, equal to the numbers in nonischaemic blood perfused myocardium [2.8(0.9)]. Conclusions: The mechanism of preconditioning is not due to attenuation of neutrophil function during reperfusion. Furthermore, substituting pyruvate for glucose in the reperfusate did not prevent the protection against infarction afforded by ischaemic preconditioning. Cardiovascular Research 1992;26: 1 195-1 198 reconditioning the heart with a brief period of ischaemia renders it, by an unidentified mechanism, P very resistant to infarction from a subsequent ischaemic insult. This, profound pfotection has been described in dogs,' pigs,-and rabbits.. The mechanism for preconditioning is not known but does not seem to involve opening of collateral vessels' or synthesis of a protective pr~tein.~ While recent work in our laboratory indicates that adenosine may be the trigger for the preconditioning response,6 the actual biochemical change responsible for the protection remains elusive.'
P very resistant to infarction from a subsequent ischaemic insult. This, profound pfotection has been described in dogs,' pigs,-and rabbits.. The mechanism for preconditioning is not known but does not seem to involve opening of collateral vessels' or synthesis of a protective pr~tein.~ While recent work in our laboratory indicates that adenosine may be the trigger for the preconditioning response,6 the actual biochemical change responsible for the protection remains elusive. ' Neutrophils are known to accumulate in reperfused myocardium and it is believed that they contribute to cell injury and necrosis.8 Antineutrophil interventions, including neutropenia,'" adhesion molecule antibodies," or antiinflammatory agents,'* l 3 have all been reported to limit infarct size. Finally, several reports indicate that adenosine can protect the heart specifically thou h an antineutrophil One possible mechanism in the reperfusion period. mechanism whereby preconditioning could protect the heart is by reducing the neutrophil mediated component of cell death that occurs during reperfusion.
In the present study we were able to prevent neutrophil accumulation by removing the heart from the rabbit after 30 minutes of regional ischaemia and reperfusing it with neutrophil free Krebs buffer. If preconditioning is the result of attenuated neutrophil function, then preconditioned hearts should have infarcts of similar size to those seen without preconditioning when neutrophil accumulation is prevented.
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The in vitro reperfusion preparation also allows us to change the composition of the reperfusate. Two recent reports indicate that the protection afforded by preconditioning is lost when pyruvate, a mitochondria1 substrate, is substituted for glucose in the reperfusate. 16 
''
The pyruvate response would suggest that preconditioning may provide an increased glycolytic capability which allows the heart to recover in the presence of injured mitochondria. Those previous studies used the recovery of mechanical function and enzyme release as indicators of injury. In the present study we were able to repeat the experiment with infarct size as the end point.
Methods

Surgical preparation of animals
New Zealand White rabbits of either sex, weighing between 1.5 and 3.2 kg, were anaesthetised with intravenous sodium pentobarbitone (30 mgkg-'). Additional anaesthesia was given during the experiment as needed. The neck was opened with a ventral midline incision, and a tracheotomy was performed. The rabbits were mechanically ventilated with a positive pressure ventilator (MD Industries, Mobile, Alabamf, USA) using 100% oxygen. Ventilation rate was 30-35 strokesmin-, and tidal volume was approximately 15 ml. The respiration rate was adjusted to keep the blood pH in the physiological range. Catheters, filled with heparinised saline (10 U m -' ) , were placed in the left carotid artery and jugular vein for blood pressure monitoring and injecting drugs, respectively. A left thoracotomy was performed in the fourth intercostal space and the pericardium was opened to expose the heart. A 2-0 silk thread was passed around a branch of the left coronary artery with a taper needle and the ends of tie were threaded through a small vinyl tube to form a snare. The coronary branch was occluded by pulling the snare, which was then fixed by clamping the tube with a mosquito haemostat. 
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cyanosis. At the end of the ischaemia, the hearts were reperfused for 2 h with either blood in situ, or Krebs buffer in vitro. Hearts were reperfused with blood by simply removing the snare, and reperfusion was confirmed by the hyperaemic appearance of the region. Krebs reperfused hearts were rapidly removed from the animal and mounted on a Langendorff apparatus 2 min before release of the snare and perfused with Krebs buffer containing (in mmol.litre-I): NaCl 118.5, KCI 4.7, MgS04 1.2, &Po4 1.2, NaHCOi 24.3, CaClz 2.5, and glucose 10. The Krebs buffer was gassed with 95% 0 2 plus 5% C02 which results in a pH of 7.4-7.5. and the temperature of the reperfusate was maintained at 37°C. The perfusion pressure was maintained at 75 mm Hg. Pacing electrodes were placed in the right atrium and the isolated heart was paced at 180 beats.min-' with pulses of 5 V and 4 ms duration. A fluid filled latex balloon. which was connected to a transducer via PE240 tubing, was inserted into the left ventricle. Balloon volume was adjusted to maintain the left ventricular systolic pressure near 90 mm Hg. Total coronary artery flow was measured by timed collection of buffer from the chamber into a graduated cylinder. After 30 minutes of ischaemia the snare was released and the segment was reperfused with Krebs buffer along with the rest of the heart. All of the procedures involving the rabbits were approved by our institutional animal care and use committee.
Measurement of infarct and risk area
At the end of each in situ study the heart was quickly removed and mounted on a LangendorfT apparatus. All hearts were flushed with room temperature saline for 60 s. The coronary branch was then reoccluded and fluorescent particles (1-10 pm in diameter from Duke Scientific Corporation, Palo Alto, CA, USA) were infused into the perfusate to mark the risk zone as the non-fluorescent tissue. The heart was frozen and then cut into 2 mm transverse slices. The slices were incubated in 1 % triphenyltetrazolium chloride ('ITC) in pH 7.4 buffer for 20 min at 37°C. TTC stains living tissue a deep red colour. After staining, the area of infarcted tissue ("TC negative tissue) and the risk zone (area lacking fluorescence under ultraviolet light) in each slice were traced. The area of infarct and risk zone were determined by planimetry of the tracing. The volume of infarcted myocardium and myocardium at risk was then calculated by multiplying the planimetered areas by the slice thickness and summing the products for each heart.
Histology
Six additional non-preconditioned hearts, three in the blood reperfused and three in the Krebs reperfused groups, were processed for histology. After the two hours of reperfusion the hearts were mounted on the Langendorff apparatus and the risk zone was marked with fluorescent particles. They were then immersion fixed in buffered Carson's fixative for 2 d. The hearts were then prepared with PAS glycogen stain which differentially stains the neutrophils. All of the neutrophils in 10 random fields were counted in both the ischaemic region and the well perfused region from each heart.
Experimental protocols
The animals were randomly divided into eight groups. All hearts underwent 30 rnin ischaemia and 2 h reperfusion. Preconditioning was achieved when indicated by 5 min ischaemia followed by 10 rnin reperfusion prior to the 30 rnin ischaemia. In group 1 (control, n=5) and group 2 (preconditioned, n=4) both ischaemia and reperfusion were performed in situ. In all other groups the hearts experienced the ischaemia in situ, and near the end of the 30 rnin ischaemic period the hearts were quickly removed and mounted on a Langendorff apparatus and perfusion with Krebs buffer was begun. Precisely 30 rnin after the onset of regional ischaemia the coronary snare was removed allowing the ischaemic zone to be reperfused with Krebs buffer. Group 3 hearts (n=12) experienced 30 rnin ischaemia while group 4 hearts (n=14) were preconditioned prior to the 30 rnin ischaemia. Groups 5 and 6 (n=5 each) were non-preconditioned, like group 3, but were reperfused with Haemodynamic data and infarct size in the eight groups buffer having half the normal Ca" (1.25 mM) and double the normal Ca" (5 mM), respectively. Groups 7 (n=7) and 8 (n=6) were identical to groups 3 and 4 except that 20 mM pyruvate was substituted for the glucose in the buffer.
Data analysis
All results are expressed as group mean (SEM). The significance of differences between groups was determined by a one way analysis of variance with a Newman Kuels post-hoc test. A p value ~0 . 0 5 was considered significant.
Results
The data were derived from 64 rabbits. The numbers in the various groups are shown in the table. An additional six rabbits were used for the histology studies.
Haemodynamic data and infarct size for all groups are summarised in the table. There were no significant differences in heart rate, mean aortic pressure (measured at the onset of the 25 rnin coronary occlusion), and the size of the risk area among any of the eight groups. The infarct size, expressed as a percentage of the area at risk, averaged 43.O(SEM 5.4)% in the non-preconditioned blood reperfused hearts. Preconditioning caused infarct size to be much smaller [8.8(4.2)%] from the same ischaemic insult. These differences in infarct size were significant (p<0.05). The infarct size in the non-preconditioned Krebs reperfused hearts was 49.9(2.4)%. Although the mean was larger than in the blood reperfused hearts, the difference was not significant. Preconditioning caused infarct sizes to be smaller in the Krebs reperfused hearts [22.9(4.1)%, p<O.O5]. There was no significant difference between infarct sizes in the preconditioned blood reperfused and Krebs reperfused hearts, or in the non-preconditioned hearts in the two groups. These data indicated that reperfusion with neutrophil free buffer did not alter infarct size nor did it block the protection afforded by preconditioning. The infarct sizes for the above four groups appear in fig 1. Reperfusion with Krebs buffer virtually eliminated neutrophils from the ischaemic zone. Histology of the ischaemic zone revealed 59.6( 15) neutrophils per 10 high power fields in blood reperfused hearts but only 2.8( I .6) in Krebs reperfused hearts. Figure 2 shows that the neutrophil count in non-ischaemic blood perfused myocardium was 2.8(2.6) per 10 high power fields. An unexpected finding in this study was the observation that removing neutrophils did not alter infarct size in non-preconditioned hearts. We were concerned that the Ca" in the Krebs buffer might be contributing to calcium loading and thus mask any protective effect derived from removing the neutrophils. To test this hypothesis we examined two groups in which Ca" was either increased or decreased. Halving reperfusate Ca" to 1.25 mM (group 5) or doubling it to 5.00 mM (group 6) had no effect on infarct size in non-preconditioning hearts 
Discussion
Our data do not support the hypothesis that preconditioning protects the myocardium from ischaemia by attenuating neutrophil function during reperfusion. We found that reperfusing the hearts with Krebs buffer, which effectively eliminated the accumulation of neutrophils in the ischaemic zone, did not alter the protection conferred by preconditioning. Recent data indicate that preconditioning may be mediated by adenosine. 6 Because adenosine has been shown to inhibit neutrophil function, one of the aims in this study was to determine whether neutrophils might play a role in the protection afforded by preconditioning. Because the protective effect of preconditioning was not altered by elimination of neutrophils, we must conclude that preconditioning does not protect by attenuating neutrophil function. It has been reported in several recent studies that isolated Krebs perfused hearts could be preconditioned, with protection reflected in the recovery of mechanical function and enz me release following a standard ischaemic insult.
It was also observed that protection would be lost if the hearts were reperfused with a buffer containing pyruvate in place of the glucose.16 l7 These data suggest that ischaemia causes a defect in the mitochondria. The preconditioned hearts appeared to be able to provide additional metabolic support through glycolysis when glucose was present, which allowed the myocytes to survive a critical convalescent period. The proposed explanation was that hearts reperfused with the mitochondria1 substrate, pyruvate, could not benefit from the added glycolytic support present in the preconditioned hearts. The present study tested that hypothesis in an infarct size model. Unfortunately, the present results did not support the theory, as preconditioning was just as protective with pyruvate as with glucose in the buffer. We have no explanation for the discrepant data except to caution that the recovery of function in the reperfused hearts reflects a combination of both necrosis and stunning. 
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The relative contributions are always unknown and factors which affect stunning may be quite different from those affecting necrosis. It would appear that pyruvate may differentially affect stunning but not necrosis. An interesting observation in the present study was that both preconditioned and non-preconditioned hearts which had neutrophils eliminated during reperfusion had similar infarct sizes to hearts reperfused in situ. In fact the infarcts tended to be larger in the Krebs reperfused hearts, although the difference was not significant. A likely explanation of that observation is that the non-physiological nature of the Krebs reperfusion killed as many cells as would have been spared by the elimination of neutrophils. What that toxic component might be is not apparent but it does not appear to be calcium as changes in the calcium concentration of the reperfusate had little effect on infarct size. The alternative explanation, of course, is that neutrophils do not contribute to necrosis in the reperfused rabbit heart.
It has been proposed that activated neutrophils contribute to reperfusion injury by either plugging the microcirculation" or attacking the myocytes in a process termed frustrated phagocytosis.* Chemotactic substances are generated in the tissue during myocardial ischaemia. At reperfusion, neutrophils respond to these chemotactic signals and enter the myocardium in quantity.' While the severity of injury is usually in proportion to the quantity of neutrophils present, a cause and effect relationship has been difficult to prove. While activated neutrophils clearly can injure myocytes in vitro,2'L2' the key question has been whether activated neutrophils attack otherwise recoverable tissue to kill a significant quantity of myocardium during reperfusion. Unfortunately, it has been impossible to make an animal completely neutropenic or to eliminate neutrophils entirely from the infarct and for this reason none of the evidence supporting the neutrophil hypothesis has offered clear proof of the theory. Therefore we cannot exclude the possibility that neutrophils may contribute to cell death in the reperfused rabbit heart.
We used tetrazolium staining after only two hours of reperfusion to visualise the infarcts in the present study. It is our experience that tetrazolium as used here is an accurate indicator of infarct size in the untreated heart but that certain interventions such as superoxide dismutase may alter the ability of the method to distinguish between living and dead tissue." The salvage induced with preconditioning in the rabbit does seem to be accurately indicated by tetrazolium, however. When infarct sizes were measured in control and preconditioned hearts by histology after three days of reperfusion, infarct sizes in both groups were virtually identical to those seen here. 3 In conclusion, we find that 30 minutes of in situ ischaemia followed by two hours of in vitro reperfusion with Krebs buffer virtually eliminates neutrophils from the ischaemic zone but has no effect on infarct size in either nonpreconditioned or preconditioned hearts. This argues against a modulation of neutrophil mediated injury as a mechanism of preconditioning. Substituting pyruvate for glucose in the reperfusate also failed to alter infarct size in either nonpreconditioned or preconditioned hearts.
